» Articles » PMID: 37850345

Ultrafast Detection of β-lactamase Resistance in from Blood Culture by Nanopore Sequencing

Overview
Date 2023 Oct 18
PMID 37850345
Authors
Affiliations
Soon will be listed here.
Abstract

This study aimed to assess the ultra-fast method using MinION™ sequencing for rapid identification of β-lactamase-producing clinical isolates from positive blood cultures. Spiked-blood positive blood cultures were extracted using the ultra-fast method and automated DNA extraction for MinION sequencing. Raw reads were analyzed for β-lactamase resistance genes. Multilocus sequence typing and β-lactamase variant characterization were performed after assembly. The ultra-fast method identified clinically relevant β-lactamase resistance genes in less than 1 h. Multilocus sequence typing and β-lactamase variant characterization required 3-6 h. Sequencing quality showed no direct correlation with pore number or DNA concentration. Nanopore sequencing, specifically the ultra-fast method, is promising for the rapid diagnosis of bloodstream infections, facilitating timely identification of multidrug-resistant bacteria in clinical samples.

Citing Articles

Short turnaround time of seven to nine hours from sample collection until informed decision for sepsis treatment using nanopore sequencing.

Ali J, Johansen W, Ahmad R Sci Rep. 2024; 14(1):6534.

PMID: 38503770 PMC: 10951244. DOI: 10.1038/s41598-024-55635-z.